We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Origenis Receives Grant to Develop New Diagnostic Tools

News   Feb 29, 2012

 
Origenis Receives Grant to Develop New Diagnostic Tools
 
 
 

RELATED ARTICLES

CRISPR Cuts Open New Avenues in CAR T-cell Therapy

News

According to a study published in the Blood journal, drug profiling and the CRISPR-Cas9 gene editing method have opened new avenues in the development of CAR T-cell therapy, used to treat leukaemia and lymphoma.

READ MORE

Studies Point to Important Role for B Cells in Promoting Anti-tumor Immunity

News

The likelihood of a patient responding to immune checkpoint blockade may depend on B cells in the tumor, located within specialized immune-cell clusters known as tertiary lymphoid structures (TLS), according to researchers at The University of Texas MD Anderson Cancer Center.

READ MORE

A Potential New Treatment for Preventing PTSD

News

A team of researchers has identified a protein complex that is elevated in patients with post-traumatic stress disorder (PTSD). The team have designed a peptide to target and interfere with the complex, this interference could help treat symptoms of the disorder.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE